Pilot Projects to Advance Harm Reduction and Public Safety Partnerships to Prevent Overdose

Nov 15, 2022

Request for Funding Applications

Application Deadline: December 23, 2022, at 11:59 p.m. ET

Acceptance Notification: January 9, 2022

The National Council for Mental Wellbeing, with support from the Centers for Disease Control and Prevention (CDC), invites organizations to apply for grant funding to support one-year pilot projects integrating harm reduction strategies and public safety initiatives.

Through a competitive Request for Funding Applications (RFA) process, up to eight implementation sites will be selected to implement evidence-based and promising strategies through collaborative partnerships with public safety to reduce risk of overdose and other drug-related harms for people who use drugs (PWUD) and people with substance use disorders (PWSUD) who are or may become justice-involved.

Awards will be made in amounts of up to $81,250 for a yearlong project beginning in January 2023. In addition to funding support, selected implementation sites will receive and participate in training and technical assistance (TTA) opportunities.

Eligible applicants will be nonprofit organizations in the U.S. that a) provide harm reduction services, including syringe services, naloxone or fentanyl test strips, peer-based overdose prevention or response, medications for opioid use disorder and linkages to substance use treatment to people who are at risk of drug overdose and b) can demonstrate current or past collaborations with public safety agencies. Download the full RFA for more details.

Applications must be submitted online by Friday, December 23, 2022, at 11:59pm ET.

Late submissions will not be accepted.

Questions? View the Frequently Asked Questions (FAQ) document or watch the recording and view the slides from the recent informational office hour session to learn more.

Please contact Rachel Cretcher at RachelC@thenationalcouncil.org with any additional questions.

This project is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $1,000,000 with 100% funded by CDC/HHS. The content is that of the authors and does not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the U.S. Government.